Delivery Order HHSN272201600008I-HHSN27200006
Award Date
4/26/17
Potential Completion Date
9/24/23
Potential Value
$533K
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC Category
AN81 - R&D- Medical: Aids Research (Basic Research)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to Advanced Bioscience Laboratories, Inc. (ABL). The $510,898.00 contract is for the development and testing of messaging to drive adoption and use of HIV prevention products among young, urban and per-urban South African women.
The contract is a delivery order under the HIV Microbicides and Biomedical Prevention 2016-2021...
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The $1,529,440.80 cost-plus-fixed-fee contract provides statistical support for HIV non-vaccine biomedical prevention product development under NIAID's "Comprehensive Resources for HIV Microbicides and Biomedical Prevention"...
This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Advanced Bioscience Laboratories, Inc. (ABL), a contract research and manufacturing organization. The $3,150,428.64 award is a delivery order under the HIV Microbicides and Biomedical Prevention 2016-2021 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. ABL will provide comprehensive resources for...
This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL) for $1,356,494.24. The contract is for statistical and pharmacometric modeling support to aid in the development of HIV non-vaccine biomedical prevention products.
The contract is part of NIAID's Comprehensive Resources for HIV Microbicides and Biomedical Prevention program, which funds product development initiatives in this area. ABL,...
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL) under the HIV Microbicides and Biomedical Prevention 2016-2021 indefinite-delivery, indefinite-quantity (IDIQ) contract. The $672,211.75 cost-plus-fixed-fee contract requires ABL to provide expertise in ethnographic research to enhance study drug adherence and uptake in human...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned for-profit manufacturer of goods. The $616,640.51 cost-plus-fixed-fee contract, which is not set aside, supports the "OVINE MODEL AND VAGINAL MICROBIOME SUPPORT FOR HIV NONVACCINE BIOMEDICAL PREVENTION PRODUCT DEVELOPMENT" under NIAID's...
This federal contract award, valued at $2,959,434.41, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL). The contract is for the synthesis and production of an HIV-1 envelope glycopeptide immunogen nanoparticle vaccine as part of NIAID's Preclinical Development Support program. This is a cost-plus-fixed-fee delivery order contract with an ultimate...
This is a $3,273,876.00 cost-plus-fixed-fee Delivery Order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Advanced Bioscience Laboratories, Inc. (ABL) for the characterization of the pharmacokinetic/pharmacodynamic (PK/PD) profile of a candidate HIV prevention drug in rhesus macaques. The contract is part of the Comprehensive Resources for HIV Microbicides and Biomedical...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The $174,091.42 cost-plus-fixed-fee contract is for planning and implementation of a NIAID consultation on advancing the development of multipurpose prevention technologies (MPTs). This is a delivery order issued under NIAID's HIV Microbicides and Biomedical Prevention 2016-2021 IDIQ...
This is a delivery order contract awarded to Advanced Bioscience Laboratories, Inc. (ABL) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS). The contract, valued at $605,156.70, is for material receipt, storage, shipping, and inventory services in support of NIAID's Comprehensive Resources for HIV Microbicides and Biomedical Prevention program. The contract is a Cost Plus Fixed Fee type and has an ultimate...